Hard pass for me on that link.
I think what you're
Hard pass for me on that link.
I think what you're feeling from ER and possibly others is the confusion of not catching any of the many gentle suggestions from actual, recognized, career writers about tidying up your billion word posts so they're more palatable. As well as the many gentle nudges from those who have made a career in biotech or the sciences to correct some glaring assumptions you continue to spin and turn and build into fanciful outcomes that aren't realistic. But nobody gets through. It happens over and over, and I think what's happening here is you're confused that you continue to get any sort of pushback because you've decided you're CYDY's pied piper?
By all means, keep doing what you're doing and never take any advice from anyone. Seriously. You can do that all you want. You're currently doing it. Honestly, it's all good. Just don't be surprised when some people aren't on board with it. Especially the ones who have tried to point out glaring issues in a post only to get a reply that basically says "well I still think I'm right".
You're running on a feedback loop fueled by confirmation bias.
And while that fuel burns, you continue to be a part of a select few who clog the boards under what appears to be the assumption that more words equals more clout. Or more intelligence, maybe? I don't know for sure.
But what I do know is that taking some criticism every once in a while, and adjusting your position based on that, isn't a weakness. It's a sign of intelligence. There are people to be learned from on this board. People who have worked in pharma/bio their entire careers in the HIV space or oncology. People who make their living improving the writing of others. People who have won countless awards writing documentaries and bump erasers with the best in the biz. Doctors, Degenerates, Dipshits. And on an on. Lots of people to learn from if you're willing to admit you might be wrong on occasion. Hell, I've been wrong plenty. Learned from my mistakes and got better for it. And I'll continue to be wrong at times, I'm sure. That's life.
At any rate, CCR5 amirite?
#Science #Leronlimab
32
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Another Step Forward at Murdock Mountain In the cutthroat world of mining exploration, hitting that sweet spot between expectation and reality is akin to finding gold. So, when Nevada Organic Phosphate Inc. (CSE: NOP, OTCQB: NOPFF) touts another solid intersection at their Murdock Mountain site, I figure it's worth a closer look. Drill Hole MM26-13, the latest contender,...
Continue Reading
Millrose's Uneasy Alliance With Trouble When it rains, it pours, doesn't it? Millrose Properties, Inc.—your friendly neighborhood real estate developer—has got itself caught in the crosshairs of a securities fraud lawsuit. Investors who've been cozying up to Millrose's stock from February 7, 2025, all the way to October 2, 2026, find themselves at the mercy of...
Continue Reading
Understanding the Complexities of Towing Think towing's a cinch? Well, buddy, think again. A tow truck and a disabled vehicle ain't as simple a match as you might think, especially when it comes to heavy-duty players like commercial trucks, RVs, and construction beasts. It's not just hook, line, and sinker here—it's an orchestra of specialized equipment and seasoned...
Continue Reading
Shaping the Skyline with Life Time Living Right in the heart of Midtown Raleigh, they're drawing lines in the sand for what the future of upscale living will look like. On October 29, Dewitt Carolinas and Life Time (NYSE: LTH) officially broke ground on Life Time Living at The Exchange Raleigh. Sure, groundbreaking ceremonies happen all the time, but this one sends a...
Continue Reading
Enterprise Networking's Growth Trajectory When the digits start rolling in at a compound annual growth rate of a neat 10.1%, you know there's a story worth watching. This tale of enterprise networking gaining traction is a head-turner, anticipated to soar from $134.59 billion in 2026 to a hefty $239.92 billion by 2032. Hold onto your hats—there's a storm of change...
Continue Reading
A Concerted Effort for Lung Cancer Awareness Picture this: communities nationwide rallying together, not just to remember but to act against lung cancer. That's exactly what's happening this November, as LUNGevity Foundation spearheads Lung Cancer Awareness Month (LCAM). It’s not just about recognition—it's action with purpose. Driving Change Through Action This...
Continue Reading
Leadership Leap for Rana Gillmon Well, we've got some buzz from AXA XL that's stirring the pot in the insurance scene, with Rana Gillmon taking on a more expansive role. She's now at the helm of client and distribution activities in the East Zone of the U.S. alongside her existing responsibilities in private equity client relations across the Americas. Sounds like a hefty...
Continue Reading
Financial Milestones and Market Insights Boy, if you're not watching TETRA Technologies (NYSE:TTI) right now, you're probably missing out on a real barnstormer of a financial report. The numbers are looking chalkboards-be-damned stellar! They’ve just notched their finest third quarter in a decade, bringing in revenues through the roof at $168 million—an impressive 10%...
Continue Reading
New Clinic Brings Specialized Care to Long Island Listen, when it comes to healthcare, especially something as life-altering as food allergies, you're not just looking for any run-of-the-mill clinic. You're looking for the right place with the right people who get it. And folks in Long Island are getting something worth celebrating—a new clinic from Latitude Food...
Continue Reading
Immunic Taps Into November Conferences Every now and then, you catch a company that's not just spinning its wheels but making some potentially big waves in their field. This time, it's Immunic, Inc. (Nasdaq: IMUX), stepping into the spotlight. They're strutting their stuff at several investor conferences this November, starting with Boston and New York, then hopping over...
Continue Reading
Top 5 Most Recently Viewed Articles
Innovative Design Concept for Alcohol Bottles The invention known as SAFE DRINKING was crafted by a creative inventor with a vision to enhance road safety when it comes to alcohol consumption. Its purpose is clear: to visibly indicate if beer or liquor is being consumed while driving, particularly during nighttime. This inventive approach aims to deter drivers from...
Continue Reading
Wavi Island: A Hidden Gem in the South Pacific A stunning private island awaits its new owner in the South Pacific. Wavi Island, spanning 27 acres, is set for a luxury auction with no reserve. Located just off the coast of Fiji's second-largest island, Vanua Levu, Wavi Island offers the perfect blend of natural beauty and exclusive living. The Unique Characteristics of...
Continue Reading
Understanding the Results of the Recent Riksbank Certificate Sale The Riksbank recently conducted a significant auction for its certificates, producing compelling results that financial analysts and investors have eagerly awaited. This auction is a reflection of the bank's ongoing efforts to manage monetary policy effectively and maintain stability in the Swedish economy....
Continue Reading
Understanding the Current Housing Market Dynamics For many potential buyers, the dream of owning a home seems increasingly out of reach. With mortgage rates hitting levels not seen in decades, those hoping to buy may find their expectations are not aligning with reality. Industry experts caution that even if the Federal Reserve cuts interest rates, it may not lead to the...
Continue Reading
Graphjet Technology Unveils Annual Report Filing Graphjet Technology, a pioneering force in the production of graphite and graphene from agricultural waste, recently made headlines by announcing the filing of its Annual Report on 10-K for the preceding fiscal year. This filing reflects the company's commitment to transparency and adherence to compliance standards set by...
Continue Reading